← Back to Search

Neurostimulation Device

Felix for Essential Tremor

N/A
Waitlist Available
Led By Rajesh Pahwa, MD
Research Sponsored by Fasikl Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 7 days
Awards & highlights

Study Summary

This trial studies how a device can help reduce tremors in adults with essential tremor or Parkinson's disease.

Eligible Conditions
  • Essential Tremor
  • Parkinson's Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 7 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 7 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Clinical Global Impression of Improvement (CGI-I)
Clinical Global Impression of Severity (CGI-S)
Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS)
+5 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: FelixExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Felix
2023
N/A
~40

Find a Location

Who is running the clinical trial?

Fasikl Inc.Lead Sponsor
1 Previous Clinical Trials
120 Total Patients Enrolled
1 Trials studying Essential Tremor
120 Patients Enrolled for Essential Tremor
Rajesh Pahwa, MDPrincipal InvestigatorUniversity of Kansas Medical Center
5 Previous Clinical Trials
422 Total Patients Enrolled
Richard B Dewey III, MDPrincipal InvestigatorParkinson's Disease and Movement Disorders Center of Boca Raton

Media Library

Felix System (Neurostimulation Device) Clinical Trial Eligibility Overview. Trial Name: NCT05842434 — N/A
Essential Tremor Research Study Groups: Felix
Essential Tremor Clinical Trial 2023: Felix System Highlights & Side Effects. Trial Name: NCT05842434 — N/A
Felix System (Neurostimulation Device) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05842434 — N/A
Essential Tremor Patient Testimony for trial: Trial Name: NCT05842434 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there any availability for participants in this experiment?

"The clinicaltrials.gov page indicates that this trial is not accepting any applicants at the moment. Originally posted on May 1st 2022 and last updated April 24th 2022, it currently lacks participants; however, there are a total of 538 other trials enrolling individuals right now."

Answered by AI

Who else is applying?

What state do they live in?
Missouri
Kansas
What site did they apply to?
University of Kansas Medical Center
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
0
2

Why did patients apply to this trial?

I have had ET in both hands my entire life. I have tried a couple medications but they did not work.
PatientReceived 2+ prior treatments
Recent research and studies
clinicaltrials.govStudy
Pilot Study of the Felix System in Patients With Essential Tremor and Parkinson's Tremor
2023. "Pilot Study of the Felix System in Patients With Essential Tremor and Parkinson's Tremor". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05842434.
~22 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top